Analysis of the potential for immunosuppression of infants with in-utero and breast milk exposure to antitumor necrosis factor alpha agents: are all agents equally safe?

Objective:. To assess the safety of tumor necrosis factor inhibitors (TNFi) during pregnancy, specifically in relation to infant infection rates, vaccine efficacy, and vaccine-associated adverse events in infants exposed to TNFi in utero and through breast milk. Data Sources:. A comprehensive litera...

Full description

Bibliographic Details

Published in:	International Journal of Women's Dermatology
Main Authors:	Marita Yaghi, MD, Ajay S. Dulai, MBBS, Nina R. Haddad, MD, Emi M. Murase, BS, Jenny E. Murase, MD
Format:	Article
Language:	English
Published:	Wolters Kluwer 2025-10-01
Online Access:	http://journals.lww.com/10.1097/JW9.0000000000000220